Financial Analysis: Aimei Health Technology (AFJK) & Its Competitors

Aimei Health Technology (NASDAQ:AFJK) is one of 89 publicly-traded companies in the “UNCLASSIFIED” industry, but how does it contrast to its rivals? We will compare Aimei Health Technology to related companies based on the strength of its institutional ownership, profitability, analyst recommendations, earnings, valuation, dividends and risk.

Profitability

This table compares Aimei Health Technology and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aimei Health Technology	N/A	-95.88%	3.06%
Aimei Health Technology Competitors	0.86%	0.95%	0.80%

Risk and Volatility

Aimei Health Technology has a beta of -0.02, indicating that its stock price is 102% less volatile than the S&P 500. Comparatively, Aimei Health Technology’s rivals have a beta of -0.08, indicating that their average stock price is 108% less volatile than the S&P 500.

Earnings and Valuation

This table compares Aimei Health Technology and its rivals gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Aimei Health Technology	N/A	$2.55 million	54.35
Aimei Health Technology Competitors	$41.01 million	-$17.16 million	92.69

Aimei Health Technology’s rivals have higher revenue, but lower earnings than Aimei Health Technology. Aimei Health Technology is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a summary of recent recommendations for Aimei Health Technology and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aimei Health Technology	1	0	0	0	1.00
Aimei Health Technology Competitors	214	263	217	3	2.01

As a group, “UNCLASSIFIED” companies have a potential upside of 66.42%. Given Aimei Health Technology’s rivals stronger consensus rating and higher probable upside, analysts clearly believe Aimei Health Technology has less favorable growth aspects than its rivals.

Insider and Institutional Ownership

45.6% of Aimei Health Technology shares are held by institutional investors. Comparatively, 52.0% of shares of all “UNCLASSIFIED” companies are held by institutional investors. 2.5% of Aimei Health Technology shares are held by company insiders. Comparatively, 42.9% of shares of all “UNCLASSIFIED” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Aimei Health Technology rivals beat Aimei Health Technology on 10 of the 13 factors compared.

About Aimei Health Technology

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.